SOLACI Research Registries were presented at the SOLACI-SBHCI 2023 Congress

The area of records within SOLACI – SOLACI Research – continues to grow and share the results of its investigations with the entire Latin American interventional community.

In this case, a dedicated session was held during the SOLACI-SBHCI 2023 Congress to present the data from the SOLACI records and to discuss the challenges of carrying out reliable research initiatives that allow extracting valuable information to support therapeutic approaches that result in a better quality of life for patients in the region.

In the first presentation, Dr. Nicolás Zaderenko presented the results to date from the Latin American Coronary Bifurcation Registry, which already includes more than 1300 patients in 10 countries in Latin America.

LATAMBif-Registry

Next, Dr. Alexandre Schaan de Quadros (BRA) was invited to present the results of LATAM CTO, a registry that is not part of SOLACI Research but collects valuable data on chronic occlusions in our region.

Later on, Dr. Maximiliano Rossi (ARG) shared the results of the SOLACI Peripheral Registry and highlighted the value of this registry because it allows access to data from patients in the region for the first time. The registry, created in 2020, surveys the reality of patients with Lower Limb Angioplasty in the region and aims to understand their clinical and angiographic characteristics. In this regard, this initiative already includes more than 1200 patients enrolled in more than 9 Latin American countries.

Registro-LATAM-Peripheral

Continuing with the session, Dr. Henrique Ribeiro (BRA) presented the TAVI Guidelines developed in conjunction with the Inter-American Society of Cardiology (SIAC). In this regard, during the symposium, the importance of having the support of a clinical society regarding data reliability was emphasized.

Finally, Dr. Pablo Lamelas, Director of SOLACI Research, presented the brand new Left Main Revascularization Guidelines, also developed with SIAC.

LM-Revasc-SOLACI-SIAC-guideline-slides-SOLACI-Rio-2023

Towards the end of the session, Dr. Mangione, former President of SOLACI, congratulated the members of the SOLACI Peripheral Registry for all the work done and encouraged them to continue working to make these registries even larger.

If you wish to join the SOLACI Research records, please write to research@solaci.org.”


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Data Update Campaign for SOLACI Members. Let’s Stay Connected

Data Update for SOLACI Members. We aim to keep our members informed about all developments and matters related to the association. In this regard, we...

Highlights of the SOLACI@EuroPCR 2025 Session

Relive the best moments of the joint session organized by SOLACI during the EuroPCR 2025 Congress on “Clinical and technical factors for decision-making in...

SOLACI Symposium at the EuroPCR 2025 Congress

The Latin American Society of Interventional Cardiology (SOLACI) makes a strong appearance once again at one of the most important congresses in the field...

See the best images from the Uruguay 2025 Sessions

Enjoy the best moments of the Uruguay 2025 Conference, held at the Radisson Hotel in Montevideo (Uruguay) on May 7, 8, and 9, 2025. <!--...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Watchman FLX and Improvement Impact vs. 2.5

Left atrial appendage occlusion (LAAO) represents an effective alternative to oral anticoagulation (OAC) in patients with non-valvular atrial fibrillation at high risk of thromboembolic...

Chronic Stent Recoil and Its Long-Term Effects

The evolution of stent technology—including new scaffold designs, thinner struts, and more biocompatible polymers—has brought about an emerging concern: the late loss of structural...

PROSPECT II Substudy: Relationship Between Different Levels of hs-CRP and Vulnerable Plaque Characteristics in Patients with NSTEMI

Inflammation plays a key role in the onset and progression of atherosclerosis and has been linked to a higher risk of cardiovascular events, regardless...